Roel Gordijn is Chief Commercial Officer at Polyplus®. In this role he manages global, sales, marketing, and scientific support teams.
Before joining Polyplus in 2021, Roel was General Manager of Gene-Therapy business at Pall Biotech. He previously held several senior management roles at Pall/Danaher, and Lonza, as Global director of Industrial Cell Culture Media Sales and Marketing.
Also Speaking
Jenny Holt
Senior Vice President, Programme and Portfolio Management • Ray Therapeutics
31 October 2022
Marco Ruella
Assistant Professor of Medicine in the Division of Hematology/Oncology and the Center for Cellular Immunotherapies • University of Pennsylvania
30 December 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023